We are monitoring the impact of COVID-19 on North America Infectious Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1246
Share on
Share on

North America Infectious Disease Therapeutics Market Research Report – Segmented By Mode Of Treatment, Target Organism, Infection Type, Distribution Channels and Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1246
Pages: 182

North America Infectious Disease Therapeutics Market Size (2021 to 2026)

The size of the North America Infectious Disease Therapeutics Market is estimated to grow USD 62.83 billion by 2026 from USD 43.08 billion in 2021, growing at a CAGR of 7.84% during the forecast period.

The increased prevalence of infectious diseases, rising funding for research and development, and rising awareness initiatives by different government and non-profit organizations contribute to the expansion of the infectious disease therapeutics market in North America. Various disease prevention programs are also being implemented across the world. Furthermore, the government, private sector, and nonprofit groups are all working to improve illness management. As a result, all of these factors are projected to contribute to market expansion. The high prevalence of malaria and other infections, the rising incidence of these disorders, and rising expenditure on preventing and detecting infectious diseases are anticipated to drive this market's expansion.

The worldwide incidence of infectious illnesses and the start of COVID-19 and increased awareness for early disease detection, a change in focus from centralized laboratories to decentralized POC testing, and technical developments are driving market expansion. In addition, the market is projected to expand due to a favorable reimbursement scenario that covers the diagnosis and treatment of various diseases. The factors driving the growth of this market are likely to be the rising prevalence of infectious diseases, rising expenditure to boost the penetration rate of treatments for these diseases, rising initiatives to raise awareness about treatments and diagnosis of these conditions, and increasing clinical trial studies for the development of new drugs. Due to the rising prevalence of infectious diseases, increased awareness of the early diagnosis of infectious diseases, and increased research funding activities by various private and government organizations, the infectious disease therapeutics market is expected to grow significantly over the forecast period.

Inadequate reimbursement is a key major obstacle to the infectious disease diagnostics market expansion. As a result, most diagnostic businesses confront a significant challenge in commercializing their tests: getting health insurance to pay for them. In addition, the global infectious diseases therapeutics industry may face a challenge when patents on infectious illness medicines expire.

This research report on the North America Infectious Disease Therapeutics Market has been segmented & sub-segmented into the following categories:

By Mode of Treatment:

  • Drugs     
  • Vaccines    

By Target Organism:

  • Antibacterial      
  • Antifungal
  • Antiviral  
  • Antiparasite      
  • others     

By Infection type: 

  • Bacterial  
  • Viral      
  • Fungal    
  • Parasitic  
  • Others    

By Distribution Channels: 

  • Hospitals  
  • Clinics     
  • Others

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, because of the growing incidence of infectious diseases and the availability of better healthcare infrastructure, the United States is anticipated to be the largest infectious disease therapeutic market. In the United States, the rate of antibiotic prescriptions is rather high. Furthermore, the trend varies substantially depending on the provider in a given state. In addition, there is an increasing prevalence of HIV in the United States and an increase in approvals for new disease treatments, all of which are projected to drive market growth. The rising number of prescriptions for infectious illness diagnostic tests is due to the diagnosis and management of such disorders. During the forecast period, these factors, together with the rising movement toward preventative care, are likely to boost demand for infectious disease diagnostics.

KEY MARKET PLAYERS:

A few of the key companies operating in the North America Infectious Disease Therapeutics Market profiled in this report are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida and Sanofi.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Mode of Treatment                

                                5.1.1 Introduction           

                                5.1.2 Drugs        

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Topical

                                                5.1.2.3 Injections

                                                5.1.2.4 Others

                                5.1.3 Vaccines  

                                5.1.4 Y-o-Y Growth Analysis, By Mode of treatment         

                                5.1.5 Market Attractiveness Analysis, By Mode of treatment        

                                5.1.6 Market Share Analysis, By Mode of treatment         

                5.2 Target Organism                      

                                5.2.1 Introduction           

                                5.2.2 Antibacterial          

                                5.2.3 Antifungal

                                5.2.4 Antiviral   

                                5.2.5 Antiparasite           

                                5.2.6 others       

                                5.2.7 Y-o-Y Growth Analysis, By Target Organism               

                                5.2.8 Market Attractiveness Analysis, By Target Organism             

                                5.2.9 Market Share Analysis, By Target Organism              

                5.3 Infection type                           

                                5.3.1 Introduction           

                                5.3.2 Bacterial   

                                5.3.3 Viral           

                                5.3.4 Fungal       

                                5.3.5 parasitic   

                                5.3.6 others       

                                5.3.7 Y-o-Y Growth Analysis, By Infection type    

                                5.3.8 Market Attractiveness Analysis, By Infection type  

                                5.3.9 Market Share Analysis, By Infection Type   

                5.4 Distribution Channels                            

                                5.4.1 Hospitals  

                                5.4.2 Clinics        

                                5.4.3 Others      

                                5.4.4 Y-o-Y Growth Analysis, By Distribution Channels     

                                5.4.5 Market Attractiveness Analysis, By Distribution Channels   

                                5.4.6 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Mode of Treatment

                                                6.1.3.3 By Target organism

                                                6.1.3.4 By Infection Type

                                                6.1.3.5 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Mode of Treatment

                                                6.1.4.3 By Target organism

                                                6.1.4.4 By Infection Type

                                                6.1.4.5 By Distribution Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Mode of Treatment

                                                6.1.5.3 By Target organism

                                                6.1.5.4 By Infection Type

                                                6.1.5.5 By Distribution Channels

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Gilead Sciences                         

                8.3 GlaxoSmithKline                      

                8.4 Johnson & Johnson                 

                8.5 Merck & Co                

                8.6 Pfizer                            

                8.7 Achillion Pharmaceuticals                    

                8.8 Novartis                       

                8.9 Abbvie                         

                8.10 Astellas Pharma                     

                8.11 AstraZeneca                            

                8.12 Auritec Pharmaceuticals                     

                8.13 Bayer                          

                8.14 Bristol-Myers Squibb                           

                8.15 Chimerix Pharmaceuticals                 

                8.16 Cubist                         

                8.17 Eli Lilly                        

                8.18 Isis Pharmaceuticals                             

                8.19 pSivida                       

                8.20 Sanofi                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Infectious Disease Therapeutics Market, By Mode of treatment, From 2021 to 2026 (USD Million)
  2. North America Drugs Market, By Region, From 2021 to 2026 (USD Million)
  3. North America vaccines Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Infectious Disease Therapeutics Market, By Target Organism, From 2021 to 2026 (USD Million)
  5. North America Antibacterial Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Antifungal Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Antiviral Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Antiparasite Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Infectious Disease Therapeutics Market, By Infection Type, From 2021 to 2026 (USD Million)
  10. North America Bacterial Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Viral Market, By Region, From 2021 to 2026 (USD Million)
  12. North America Fungal Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Parasitic Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Infectious Disease Therapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Million)
  15. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Clinics Market, By Region, From 2021 to 2026 (USD Million)
  17. United States Infectious Disease Therapeutics Market, By Mode of treatment, From 2021 to 2026 (USD Million)
  18. United States Infectious Disease Therapeutics Market, By Target Organism, From 2021 to 2026 (USD Million)
  19. United States Infectious Disease Therapeutics Market, By Infection Type, From 2021 to 2026 (USD Million)
  20. United States Infectious Disease Therapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Million)
  21. Canada Infectious Disease Therapeutics Market, By Mode of treatment, From 2021 to 2026 (USD Million)
  22. Canada Infectious Disease Therapeutics Market, By Target Organism, From 2021 to 2026 (USD Million)
  23. Canada Infectious Disease Therapeutics Market, By Infection Type, From 2021 to 2026 (USD Million)
  24. Canada Infectious Disease Therapeutics Market, By Distribution Channels, From 2021 to 2026 (USD Million)
  25. North America Infectious disease Therapeutics Market, By Drugs, From 2021 to 2026 (USD Million)
  26. North America Oral Administration Market, By Region, From 2021 to 2026 (USD Million)
  27. North America Topical Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Injections Market, By Region, From 2021 to 2026 (USD Million)
  29. United States Infectious disease Therapeutics Market, By Drugs, From 2021 to 2026 (USD Million)
  30. Canada Infectious disease Therapeutics Market, By Drugs, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample